Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C

Autor: Clifford W. Sachs, Robert L. Fine, Steadman D. Harrison, Ahmad R. Safa
Rok vydání: 1995
Předmět:
Cell Survival
Cell
Antineoplastic Agents
Breast Neoplasms
Safingol
Vinblastine
Biochemistry
Cell Line
Substrate Specificity
chemistry.chemical_compound
Sphingosine
medicine
Tumor Cells
Cultured

Animals
Humans
ATP Binding Cassette Transporter
Subfamily B
Member 1

Enzyme Inhibitors
skin and connective tissue diseases
Myristoylated Alanine-Rich C Kinase Substrate
Molecular Biology
Protein kinase C
Phorbol 12
13-Dibutyrate

Protein Kinase C
P-glycoprotein
biology
Cell Membrane
Daunorubicin
Intracellular Signaling Peptides and Proteins
Brain
Membrane Proteins
Proteins
Affinity Labels
Cell Biology
Molecular biology
Drug Resistance
Multiple

Recombinant Proteins
Rats
medicine.anatomical_structure
chemistry
Verapamil
Cell culture
Doxorubicin
biology.protein
Phorbol
Phosphorylation
Female
medicine.drug
Zdroj: The Journal of biological chemistry. 270(44)
ISSN: 0021-9258
Popis: Safingol is a lysosphingolipid protein kinase C (PKC) inhibitor that competitively interacts at the regulatory phorbol binding domain of PKC. We investigated the effects of safingol on antineoplastic drug sensitivity and PKC activity of MCF-7 tumor cell lines. Safingol treatment of 32P-labeled MCF-7 WT and MCF-7 DOXR cells inhibited phosphorylation of the myristoylated alanine-rich protein kinase C substrate in both cell lines, suggesting inhibition of cellular PKC. However, only in MCF-7 DOXR cells did safingol treatment increase accumulation of [3H]vinblastine and enhance toxicity of Vinca alkaloids and anthracyclines. Drug accumulation changes in MCF-7 DOXR cells treated with safingol were accompanied by inhibition of basal and phorbol 12,13-dibutyrate-stimulated phosphorylation of P-glycoprotein (P-gp). Expression of P-gp and levels of mdr1 message in MCF-7 DOXR cells were not altered by safingol treatment alone or in combination with vinblastine. Treatment of MCF-7 DOXR cell membranes with safingol did not inhibit [3H]vinblastine binding or [3H]azidopine photoaffinity labeling of P-gp. Furthermore, safingol did not stimulate P-gp ATPase activity in membranes prepared from MCF-7 DOXR cells. We conclude that enhanced drug accumulation and sensitivity in MCF-7 DOXR cells treated with safingol are correlated with inhibition of PKC rather than competitive interference with P-gp drug binding through direct interaction with P-glycoprotein.
Databáze: OpenAIRE